Abstract
Growing evidence supports the existence of a subpopulation of cancer cells with stem cell characteristics within tumors. As occurs with normal embryogenesis, epigenetic changes define the balance between pluripotency and differentiation in cancer stem cells (CSCs). The basis and implications of this novel concept are discussed, together with the evidence supporting a role for epigenetic mechanisms in the induction of CSCs. We discuss the evidence favoring the plasticity of these mechanisms and its potential therapeutic implications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Evans, M.J., and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156.
Fuchs, E., and Segre, J.A. (2000) Stem cells: a new lease on life. Cell 100, 143–155.
Niwa, H. (2007) How is pluripotency determined and maintained? Development 134, 635–646.
Bernstein, B.E., Mikkelsen, T.S., Xie, X. et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326.
Cowan, C.A., Atienza, J., Melton, D.A. et al. (2005) Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369–1373.
Shukla, V., Vaissiere, T. and Herceg, Z. (2008) Histone acetylation and chromatin signature in stem cell identity and cancer. Mutat Res 637, 1–15.
Visvader, J.E., and Lindeman, G.J. (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755–768.
Stingl, J., and Caldas, C. (2007) Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7, 791–799.
Weissman, I.L. (2005) Normal and neoplastic stem cells. Novartis Found Symp 265, 35–50; discussion 50–34, 92–37.
Niwa, H. (2007) Open conformation chromatin and pluripotency. Genes Dev 21, 2671–2676.
Barnhart, B.C., and Simon, M.C. (2007) Metastasis and stem cell pathways. Cancer Metastasis Rev 26, 261–271.
Feinberg, A.P., Ohlsson, R. and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7, 21–33.
Bibikova, M., Chudin, E., Wu, B. et al. (2006) Human embryonic stem cells have a unique epigenetic signature. Genome Res 16, 1075–1083.
Meshorer, E., Yellajoshula, D., George, E. et al. (2006) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10, 105–116.
Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21.
Spivakov, M., and, Fisher, A.G. (2007) Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8, 263–271.
Irizarry, R.A., Ladd-Acosta, C., Wen, B. et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178–186.
Bernstein, B.E., Meissner, A., and Lander, E.S. (2007) The mammalian epigenome. Cell 128, 669–681.
Farthing, C.R., Ficz, G., Ng, R.K. et al. (2008) Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet 4, e1000116.
Reik, W. (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425–432.
Monk, M., Boubelik, M., and Lehnert, S. (1987) Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99, 371–382.
Kafri, T., Ariel, M., Brandeis, M. et al. (1992) Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev. 6, 705–714.
Freitag, M., and Selker, E.U. (2005) Controlling DNA methylation: many roads to one modification. Curr. Opin. Genet. Dev. 15, 191–199.
Turek-Plewa, J., and, Jagodzinski, P.P. (2005) The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol. Biol. Lett. 10, 631–647.
Okano, M., Bell, D.W., Haber, D.A. et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257.
Weih, F., Nitsch, D., Reik, A. et al. (1991) Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J 10, 2559–2567.
Campanero, M.R., Armstrong, M.I., and Flemington, E.K. (2000) CpG methylation as a mechanism for the regulation of E2F activity. Proc. Natl. Acad. Sci. USA 97, 6481–6486.
Eden, S., Hashimshony, T., Keshet, I. et al. (1998) DNA methylation models histone acetylation. Nature 394, 842.
Bird, A.P., and Wolffe, A.P. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451–454.
Bannister, A.J., Zegerman, P., Partridge, J.F. et al. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120–124.
Lachner, M., O’Carroll, D., Rea, S. et al. (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116–120.
Ringrose, L., Ehret, H., and Paro, R. (2004) Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. Mol. Cell. 16, 641–653.
Wernig, M., Meissner, A., Foreman, R. et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324.
Golan-Mashiach, M., Dazard, J.E., Gerecht-Nir, S. et al. (2005) Design principle of gene expression used by human stem cells: implication for pluripotency. FASEB J 19, 147–149.
Jackson, M., Krassowska, A., Gilbert, N. et al. (2004) Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 24, 8862–8871.
Zvetkova, I., Apedaile, A., Ramsahoye, B. et al. (2005) Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 37, 1274–1279.
Calvisi, D.F., Ladu, S., Gorden, A. et al. (2007) Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 117, 2713–2722.
Suzuki, K., Suzuki, I., Leodolter, A. et al. (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9, 199–207.
Jones, P.A., and,Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428
Baylin, S.B., and Ohm, J.E. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107–116.
Issa, J.P. (2004) CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988–993.
Ohm, J.E., McGarvey, K.M., Yu, X. et al. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237–242.
Cheng, A.S., Culhane, A.C., Chan, M.W. et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 68, 1786–1796.
Calvanese, V., Horrillo, A., Hmadcha, A. et al. (2008) Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE 3, e3294.
Meissner, A., Mikkelsen, T.S., Gu, H. et al. (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766–770.
Widschwendter, M., Fiegl, H., Egle, D. et al. (2007) Epigenetic stem cell signature in cancer. Nat. Genet. 39, 157–158.
Schuebel, K., Chen, W., and Baylin, S.B. (2006) CIMPle origin for promoter hypermethylation in colorectal cancer? Nat Genet 38, 738–740.
Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A. et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983–3988.
Bloushtain-Qimron, N., Yao, J., Snyder, E.L. et al. (2008) Cell type-specific DNA methylation patterns in the human breast. Proc. Natl. Acad. Sci. USA 105, 14076–14081.
Shipitsin, M., Campbell, L.L., Argani, P. et al. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259–273.
Dontu, G., Abdallah, W.M., Foley, J.M. et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253–1270.
Singh, S.K., Hawkins, C., Clarke, I.D. et al. (2004) Identification of human brain tumour initiating cells. Nature 432, 396–401.
Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E. et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115.
Yi, J.M., Tsai, H.C., Glockner, S.C. et al. (2008) Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res. 68, 8094–8103.
Brunner, A.L., Johnson, D.S., Kim, S.W. et al. (2009) Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res 19, 1044–1056.
Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693–705.
Strahl, B.D. and Allis, C.D. (2000) The language of covalent histone modifications. Nature 403, 41–45
McGarvey, K.M., Fahrner, J.A., Greene, E. et al. (2006) Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer research 66, 3541–3549.
Berezikov, E., Guryev, V., van de Belt, J. et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120, 21–24.
Gartel, A.L., and Kandel, E.S. (2006) RNA interference in cancer. Biomol. Engg. 23, 17–34.
Park, S.M., Shell, S., Radjabi, A.R. et al. (2007) Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6, 2585–2590.
Yu, F., Yao, H., Zhu, P. et al. (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109–1123.
Iorio, M.V., Ferracin, M., Liu, C.G. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Research 65, 7065–7070.
Shell, S., Park, S.M., Radjabi, A.R. et al. (2007) Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. USA 104, 11400–11405.
Garzia, L., Andolfo, I., Cusanelli, E. et al. (2009) MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 4, e4998.
Holst, C.R., Nuovo, G.J., Esteller, M. et al. (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596–1601.
Kawakami, K., Ruszkiewicz, A., Bennett, G. et al. (2006) DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer 94, 593–598.
Minucci, S., and Pelicci, P.G. (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6, 38–51.
Yoo, C.B. and Jones, P.A. (2006) Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Disc. 5, 37–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ouzounova, M., Hernandez-Vargas, H., Herceg, Z. (2011). Epigenetic Identity in Cancer Stem Cells. In: Appasani, K., Appasani, R. (eds) Stem Cells & Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-860-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-860-7_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-859-1
Online ISBN: 978-1-60761-860-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)